Ante la gran cantidad de información circulante respecto a los medicamentos para el tratamiento de COVID-19 y considerando que es necesario ser objetivos respecto a la información fiable y científica disponible referente ...

Background To summarize the antiviral activities of remdesivir against SARS-CoV-2, the causative agent of COVID-19. Methods Available publications were systematically explored on some databases and gray literature was ...

Si bien existe plausibilidad biológica para el uso de remdesivir en infecciones virales como las causadas por el nuevo coronavirus SARS-CoV-2, el verdadero lugar de este medicamento en el tratamiento de COVID-19 se conocerá ...

Recent efforts to repurpose drugs to combat COVID-19 have identified Remdesivir as a candidate. It acts on the RNA-dependent, RNA polymerase (RdRp) of the SARS-CoV-2 virus, a protein complex responsible for mediating ...

The COVID-19 pandemic prompted the FDA to authorize a new nucleoside analogue, remdesivir, for emergency use in affected individuals. We examined the effects of its active metabolite, remdesivir triphosphate (RTP), on the ...

La Red Argentina de Centros de Información de Medicamentos (RACIM) elaboró fichas técnicas para profesionales de la salud sobre otros tratamientos que se están investigando en pacientes con COVID-19, en el marco de ensayos ...

The broad-spectrum antiviral Remdesivir, a monophosphate nucleoside analogue prodrug (ProTide), was repurposed. In May 2020, it received emergency approval by the FDA, being the first drug approved to fight the new coronavirus ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative viral pathogen of coronavirus disease 2019 (COVID-19), appears to have various clinical presentations and may result in severe respiratory ...

OBJECTIVE: Studies in the literature regarding the use of remdesivir to treat COVID-19 patients have shown conflicting results. This study sought to answer questions related to the use of remdesivir for the treatment of ...